Alnylam Pharmaceuticals
ALNY
#600
Rank
$41.44 B
Marketcap
$310.58
Share price
0.70%
Change (1 day)
31.18%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company